Coalition of biology and chemistry for ameliorating antimicrobial drug discovery

Frontiers in Microbiology

Volumn 8, Issue MAY, 2017, Pages

  Dhakal, Dipesh ^a   Sohng, Jae Kyung ^a  

^a SunMoon University   (South Korea)

Author keywords

Antimicrobial drugs; Biological engineering; Chemical synthesis methods; Metabolic engineering; Synthetic biology

Indexed keywords

ANTIINFECTIVE AGENT; MOLECULAR SCAFFOLD;

ACTINOBACTERIA; BINDING SITE; BIOAVAILABILITY; BIOLOGICAL ACTIVITY; BIOLOGY; CHEMICAL REACTION KINETICS; COMPUTATIONAL FLUID DYNAMICS; COMPUTER MODEL; COST EFFECTIVENESS ANALYSIS; DRUG SYNTHESIS; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE EXPRESSION; GENOME; METABOLIC ENGINEERING; NANOMEDICINE; NONHUMAN; NOTE; PHENOTYPE; SYNTHETIC BIOLOGY;

EID: 85019659009     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.00734     Document Type: Note

References (67)

1. Abed, N., Saïd-Hassane, F., Zouhiri, F., Mougin, J., Nicolas, V., Desmaële, D., et al. (2015). An efficient system for intracellular delivery of beta-lactam antibiotics to overcome bacterial resistance. Sci. Rep. 5:13500. doi: 10.1038/srep13500
2. Adrio, J. L., and Demain, A. L. (2006). Genetic improvement of processes yielding microbial products. FEMS Microbiol. Rev. 30, 187-214. doi: 10.1111/j.1574-6976.2005.00009.x
3. Alper, H., Fischer, C., Nevoigt, E., and Stephanopoulos, G. (2005). Tuning genetic control through promoter engineering. Proc. Natl. Acad. Sci. U.S.A. 102, 12678-12683. doi: 10.1073/pnas.0504604102
4. Anthouard, R., and DiRita, V. J. (2015). Chemical biology applied to the study of bacterial pathogens. Infect. Immun. 83, 456-469. doi: 10.1128/IAI.02021-14
5. Anyaogu, D. C., and Mortensen, U. H. (2015). Heterologous production of fungal secondary metabolites in Aspergilli. Front. Microbiol. 6:77. doi: 10.3389/fmicb.2015.00077
6. Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E. M., Linder, T., Wawrosch, C., Uhrin, P., et al. (2015). Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol. Adv. 33, 1582-1614. doi: 10.1016/j.biotechadv.2015.08.001
7. Berdy, J. (2005). Bioactive microbial metabolites. J. Antibiot. 58, 1-26. doi: 10.1038/ja.2005.1
8. Bertrand, S., Bohni, N., Schnee, S., Schumpp, O., Gindro, K., and Wolfender, J. L. (2014). Metabolite induction via microorganism co-culture: a potential way to enhance chemical diversity for drug discovery. Biotechnol. Adv. 32, 1180-1204. doi: 10.1016/j.biotechadv.2014.03.001
9. Butler, M. S., Robertson, A. A., and Cooper, M. A. (2014). Natural product and natural product derived drugs in clinical trials. Nat. Prod. Rep. 31, 1612-1661. doi: 10.1039/C4NP00064A
10. Chemler, J. A., and Koffas, M. A. (2008). Metabolic engineering for plant natural product biosynthesis in microbes. Curr. Opin. Biotechnol. 19, 597-605. doi: 10.1016/j.copbio.2008.10.011
11. Conrado, R. J., Wu, G. C., Boock, J. T., Xu, H., Chen, S. Y., Lebar, T., et al. (2012). DNA-guided assembly of biosynthetic pathways promotes improved catalytic efficiency. Nucleic Acids Res. 40, 1879-1889. doi: 10.1093/nar/gkr888
12. Delebecque, C. J., Lindner, A. B., Silver, P. A., and Aldaye, F. A. (2011). Organization of intracellular reactions with rationally designed RNA assemblies. Science 333, 470-474. doi: 10.1126/science.1206938
13. Demain, A. L., and Sanchez, S. (2009). Microbial drug discovery: 80 years of progress. J. Antibiot. 62, 5-16. doi: 10.1038/ja.2008.16
14. Dhakal, D., Chaudhary, A. K., Yi, J. S., Pokhrel, A. R., Shrestha, B., Parajuli, P., et al. (2016). Enhanced production of nargenicin A1 and creation of a novel derivative using a synthetic biology platform. Appl. Microbiol. Biotechnol. 100, 9917-9931. doi: 10.1007/s00253-016-7705-3
15. Dhakal, D., Le, T. T., Pandey, R. P., Jha, A. K., Gurung, R., Parajuli, P., et al. (2015). Enhanced production of nargenicin A1 and generation of novel glycosylated derivatives. Appl. Biochem. Biotechnol. 175, 2934-2949. doi: 10.1007/s12010-014-1472-3
16. Dhakal, D., and Sohng, J. K. (2015). Commentary: toward a new focus in antibiotic and drug discovery from the Streptomyces arsenal. Front. Microbiol. 6:727. doi: 10.3389/fmicb.2015.00727
17. Dueber, J. E., Wu, G. C., Malmirchegini, G. R., Moon, T. S., Petzold, C. J., Ullal, A. V., et al. (2009). Synthetic protein scaffolds provide modular control over metabolic flux. Nat. Biotechnol. 27, 753-759. doi: 10.1038/nbt.1557
18. Galanie, S., Thodey, K., Trenchard, I. J., Interrante, M. F., and Smolke, C. D. (2015). Complete biosynthesis of opioids in yeast. Science 349, 1095-1100. doi: 10.1126/science.aac9373
19. Goers, L., Freemont, P., and Polizzi, K. M. (2014). Co-culture systems and technologies: taking synthetic biology to the next level. J. R. Soc. Interface 11:20140065. doi: 10.1098/rsif.2014.0065
20. Gomez-Escribano, J. P., and Bibb, M. J. (2011). Engineering Streptomyces coelicolor for heterologous expression of secondary metabolite gene clusters. Microb. Biotechnol. 4, 207-215. doi: 10.1111/j.1751-7915.2010.00219.x
21. Goss, R. J., Shankar, S., and Fayad, A. A. (2012). The generation of "unnatural" products: synthetic biology meets synthetic chemistry. Nat. Prod. Rep. 29, 870-889. doi: 10.1039/c2np00001f
22. Gurunathan, S., Han, J. W., Kwon, D. N., and Kim, J. H. (2014). Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res. Lett. 9:373. doi: 10.1186/1556-276X-9-373
23. Harvey, A. L., Edrada-Ebel, R., and Quinn, R. J. (2015). The re-emergence of natural products for drug discovery in the genomics era. Nat. Rev. Drug Discov. 14, 111-129. doi: 10.1038/nrd4510
24. Harvey, C. J., Puglisi, J. D., Pande, V. S., Cane, D. E., and Khosla, C. (2012). Precursor directed biosynthesis of an orthogonally functional erythromycin analogue: selectivity in the ribosome macrolide binding pocket. J. Am. Chem. Soc. 134, 12259-12265. doi: 10.1021/ja304682q
25. Hayashi, M. A., Bizerra, F. C., and Da-Silva, P. I. (2013). Antimicrobial compounds from natural sources. Front. Microbiol. 4:195. doi: 10.3389/fmicb.2013.00195
26. Hong, J. (2011). Role of natural product diversity in chemical biology. Curr. Opin. Chem. Biol. 15, 350-354. doi: 10.1016/j.cbpa.2011.03.004
27. Jha, A. K., Dhakal, D., Van, P. T. T., Pokhrel, A. R., Yamaguchi, T., Jung, H. J., et al. (2015). Structural modification of herboxidiene by substrate-flexible cytochrome P450 and glycosyltransferase. Appl. Microbiol. Biotechnol. 99, 3421-3431. doi: 10.1007/s00253-015-6431-6
28. Keasling, J. D. (2012). Synthetic biology and the development of tools for metabolic engineering. Metab. Eng. 14, 189-195. doi: 10.1016/j.ymben.2012.01.004
29. Kennedy, J. (2008). Mutasynthesis, chemobiosynthesis, and back to semi-synthesis: combining synthetic chemistry and biosynthetic engineering for diversifying natural products. Nat. Prod. Rep. 25, 25-34. doi: 10.1039/B707678A
30. Kim, E., Moore, B. S., and Yoon, Y. J. (2015). Reinvigorating natural product combinatorial biosynthesis with synthetic biology. Nat. Chem. Biol. 11, 649-659. doi: 10.1038/nchembio.1893
31. Kirschning, A., Taft, F., and Knobloch, T. (2007). Total synthesis approaches to natural product derivatives based on the combination of chemical synthesis and metabolic engineering. Org. Biomol. Chem. 5, 3245-3259. doi: 10.1039/b709549j
32. Kolter, R., and van Wezel, G. P. (2016). Goodbye to brute force in antibiotic discovery? Nat. Microbiol. 1:15020. doi: 10.1038/nmicrobiol.2015.20
33. Komatsu, M., Komatsu, K., Koiwai, H., Yamada, Y., Kozone, I., Izumikawa, M., et al. (2013). Engineered Streptomyces avermitilis host for heterologous expression of biosynthetic gene cluster for secondary metabolites. ACS Synth. Biol. 2, 384-396. doi: 10.1021/sb3001003
34. Koryakina, I., Kasey, C., McArthur, J. B., Lowell, A. N., Chemler, J. A., et al. (2016). Inversion of extender unit selectivity in the erythromycin polyketide synthase by acyltransferase domain engineering. ACS. Chem. Biol. 12, 114-123. doi: 10.1021/acschembio.6b00732
35. Lam, S. J., O'Brien-Simpson, N. M., Pantarat, N., Sulistio, A., Wong, E. H., Chen, Y. Y., et al. (2016). Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers. Nat. Microbiol. 1:16162. doi: 10.1038/nmicrobiol.2016.162
36. Lee, J. W., Na, D., Park, J. M., Lee, J., Choi, S., and Lee, S. Y. (2012). Systems metabolic engineering of microorganisms for natural and non-natural chemicals. Nat. Chem. Biol. 8, 536-546. doi: 10.1038/nchembio.970
37. Lee, S. H., Wang, H., Labroli, M., Koseoglu, S., Zuck, P., Mayhood, T., et al. (2016). TarO-specific inhibitors of wall teichoic acid biosynthesis restore β-lactam efficacy against methicillin-resistant staphylococci. Sci. Transl. Med. 8, 329ra32. doi: 10.1126/scitranslmed.aad7364
38. Li, Y., Li, Z., Yamanaka, K., Xu, Y., Zhang, W., Vlamakis, H., et al. (2015). Directed natural product biosynthesis gene cluster capture and expression in the model bacterium Bacillus subtilis. Sci. Rep. 5:9383. doi: 10.1038/srep09383
39. Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., et al. (2015). A new antibiotic kills pathogens without detectable resistance. Nature 517, 455-459. doi: 10.1038/nature14098
40. Luo, Y., Li, B. Z., Liu, D., Zhang, L., Chen, Y., Jia, B., et al. (2015). Engineered biosynthesis of natural products in heterologous hosts. Chem. Soc. Rev. 44, 5265-5290. doi: 10.1039/C5CS00025D
41. Medema, M. H., Breitling, R., Bovenberg, R., and Takano, E. (2011). Exploiting plug-and-play synthetic biology for drug discovery and production in microorganisms. Nat. Rev. Microbiol. 9, 131-137. doi: 10.1038/nrmicro2478
42. Medema, M. H., van Raaphorst, R., Takano, E., and Breitling, R. (2012). Computational tools for the synthetic design of biochemical pathways. Nat. Rev. Microbiol. 10, 191-202. doi: 10.1038/nrmicro2717
43. Meneguetti, B. T., MacHado, L. D., Oshiro, K. G., Nogueira, M. L., Carvalho, C. M., and Franco, O. L. (2016). Antimicrobial peptides from fruits and their potential use as biotechnological tools-a review and outlook. Front. Microbiol. 7:2136. doi: 10.3389/fmicb.2016.02136
44. Newman, D. J., and Cragg, G. M. (2012). Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75, 311-335. doi: 10.1021/np200906s
45. Nielsen, D. R., and Moon, T. S. (2013). From promise to practice, the role of synthetic biology in green chemistry. EMBO Rep. 14, 1034-1038. doi: 10.1038/embor.2013.178
46. Nielsen, J., Fussenegger, M., Keasling, J., Lee, S. Y., Liao, J. C., Prather, K., et al. (2014). Engineering synergy in biotechnology. Nat. Chem. Biol. 10, 319-322. doi: 10.1038/nchembio.1519
47. Nyerges, á., Csörgo, B., Nagy, I., Bálint, B., Bihari, P., Lázár, V., et al. (2016). A highly precise and portable genome engineering method allows comparison of mutational effects across bacterial species. Proc. Natl. Acad. Sci. U.S.A. 113, 2502-2507. doi: 10.1073/pnas.1520040113
48. Pimentel-Elardo, S. M., Sørensen, D., Ho, L., Ziko, M., Bueler, S. A., Lu, S., et al. (2015). Activity-independent discovery of secondary metabolites using chemical elicitation and cheminformatic inference. ACS Chem. Biol. 10, 2616-2623. doi: 10.1021/acschembio.5b00612
49. Polpass, A. J., and Jebakumar, S. R. D. (2013). Non-streptomycete actinomycetes nourish the current microbial antibiotic drug discovery. Front. Microbiol. 4:240. doi: 10.3389/fmicb.2013.00240
50. Porro, D., Branduardi, P., Sauer, M., and Mattanovich, D. (2014). Old obstacles and new horizons for microbial chemical production. Curr. Opin. Biotechnol. 30, 101-106. doi: 10.1016/j.copbio.2014.06.009
51. Ross, A. C., Gulland, L. E., Dorrestein, P. C., and Moore, B. S. (2014). Targeted capture and heterologous expression of the Pseudoalteromonas alterochromide gene cluster in Escherichia coli represents a promising natural product exploratory platform. ACS Synth. Biol. 4, 414-420. doi: 10.1021/sb500280q
52. Salis, H. M., Mirsky, E. A., and Voigt, C. A. (2009). Automated design of synthetic ribosome binding sites to control protein expression. Nat. Biotechnol. 27, 946-950. doi: 10.1038/nbt.1568
53. Singh, P., Kim, Y. J., Wang, C., Mathiyalagan, R., El-Agamy Farh, M., and Yang, D. C. (2016). Biogenic silver and gold nanoparticles synthesized using red ginseng root extract, and their applications. Artif. Cells Nanomed. Biotechnol. 44, 811-816. doi: 10.3109/21691401.2015.1008514
54. Stephanopoulos, G. (2012). Synthetic biology and metabolic engineering. ACS Synth. Biol. 1, 514-525. doi: 10.1021/sb300094q
55. Stephanopoulos, G., and Vallino, J. J. (1991). Network rigidity and metabolic engineering in metabolite overproduction. Science 252, 1675-1681. doi: 10.1126/science.1904627
56. Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., and Xia, Y. (2014). Engineered nanoparticles for drug delivery in cancer therapy. Angew. Chem. Int. Ed. Engl. 53, 12320-12364. doi: 10.1002/anie.201403036
57. Wang, H., Gill, C. J., Lee, S. H., Mann, P., Zuck, P., Meredith, T. C., et al. (2013). Discovery of wall teichoic acid inhibitors as potential anti-MRSA β-lactam combination agents. Chem. Biol. 20, 272-284. doi: 10.1016/j.chembiol.2012.11.013
58. Wang, H., Russa, M. L., and Qi, L. S. (2016). CRISPR/Cas9 in genome editing and beyond. Annu. Rev. Biochem. 85, 227-264. doi: 10.1146/annurev-biochem-060815-014607
59. Weissman, K. J. (2007). Mutasynthesis-uniting chemistry and genetics for drug discovery. Trends Biotechnol. 25, 139-142. doi: 10.1016/j.tibtech.2007.02.004
60. Winn, M., Fyans, J. K., Zhuo, Y., and Micklefield, J. (2016). Recent advances in engineering nonribosomal peptide assembly lines. Nat. Prod. Rep. 33, 317-347. doi: 10.1039/C5NP00099H
61. Xie, X., Tao, Q., Zou, Y., Zhang, F., Guo, M., Wang, Y., et al. (2011). PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. J. Agric. Food Chem. 59, 9280-9289. doi: 10.1021/jf202135j
62. Yamazaki, H., Rotinsulu, H., Narita, R., Takahashi, R., and Namikoshi, M. (2015). Induced Production of halogenated epidithiodiketopiperazines by a marine-derived Trichoderma cf. brevicompactum with sodium halides. J. Nat. Prod. 78, 2319-2321. doi: 10.1021/acs.jnatprod.5b00669
63. Yan, Y., Chen, J., Zhang, L., Zheng, Q., Han, Y., Zhang, H., et al. (2013). Multiplexing of combinatorial chemistry in antimycin biosynthesis: expansion of molecular diversity and utility. Angew. Chem. Int. Ed. Engl. 52, 12308-12312. doi: 10.1002/anie.201305569
64. Yu, K., Liu, C., Kim, B. G., and Lee, D. Y. (2015). Synthetic fusion protein design and applications. Biotechnol. Adv. 33, 155-164. doi: 10.1016/j.biotechadv.2014.11.005
65. Zhang, H., Wang, Y., Wu, J., Skalina, K., and Pfeifer, B. A. (2010). Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host. Chem. Biol. 17, 1232-1240. doi: 10.1016/j.chembiol.2010.09.013
66. Ziemert, N., Alanjary, M., and Weber, T. (2016). The evolution of genome mining in microbes-a review. Nat. Prod. Rep. 33, 988-1005. doi: 10.1039/C6NP00025H
67. Zipperer, A., Konnerth, M. C., Laux, C., Berscheid, A., Janek, D., Weidenmaier, C., et al. (2016). Human commensals producing a novel antibiotic impair pathogen colonization. Nature 535, 511-516. doi: 10.1038/nature18634